Trials / Completed
CompletedNCT03774576
A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants
A Non-Randomized, Open Label, One Sequence, Two-Period Cross-Over Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effect of multiple oral doses of itraconazole on the pharmacokinetics of RO7017773 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | RO7017773 | Single doses of RO7017773 |
| DRUG | Itraconazole | Multiple doses of Itraconazole |
Timeline
- Start date
- 2018-12-17
- Primary completion
- 2019-03-14
- Completion
- 2019-03-14
- First posted
- 2018-12-13
- Last updated
- 2020-05-07
- Results posted
- 2020-05-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03774576. Inclusion in this directory is not an endorsement.